NCT04569058View on ClinicalTrials.gov

Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents with ADHD

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
AutismAttention Deficit Hyperactivity Disorder
Interventions
DEVICE

Transcranial Photobiomodulation

Transcranial Photobiomodulation--a noninvasive intervention in which near-infrared light (850 nanometer) is applied to forebrain.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT04569058 - Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents with ADHD | Biotech Hunter | Biotech Hunter